EZZ Life Science Holdings (ASX:EZZ) Accounts Payable & Accrued Expense : A$4.40 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings Accounts Payable & Accrued Expense?

EZZ Life Science Holdings's quarterly accounts payable & accrued expense increased from Dec. 2022 (A$2.00 Mil) to Jun. 2023 (A$2.21 Mil) and increased from Jun. 2023 (A$2.21 Mil) to Dec. 2023 (A$4.40 Mil).

EZZ Life Science Holdings's annual accounts payable & accrued expense increased from Jun. 2021 (A$1.64 Mil) to Jun. 2022 (A$2.43 Mil) but then declined from Jun. 2022 (A$2.43 Mil) to Jun. 2023 (A$2.21 Mil).

EZZ Life Science Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for EZZ Life Science Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings Accounts Payable & Accrued Expense Chart

EZZ Life Science Holdings Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

3.20

1.64

2.43

2.21

EZZ Life Science Holdings Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			1.57	2.43	2.00	2.21	4.40

EZZ Life Science Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

EZZ Life Science Holdings (ASX:EZZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

104 Derby Street, Silverwater, NSW, AUS, 2128

Website

https://www.ezzlife.com.au

EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines